What Will Analytical Science Look Like in 2036? Part Two: Beyond AI

• October 20, 2026

FDA approves dostarlimab for advanced rectal cancer

The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.

• by Mouj Hijazi

• October 19, 2026

• 3 min

Reading Skin Cancer’s Molecular Fingerprint

Machine-learning models analyzed Raman spectra to distinguish cancerous tissue from normal skin

• October 13, 2026

• 3 min

Industry Insights: Scanning the Path Ahead

Devika Gholap shares how smarter scanners and changing habits could accelerate the transition to digital pathology

• by Helen Bristow

• October 15, 2026

• 7 min